Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
52.72
-0.07 (-0.13%)
At close: Apr 2, 2026, 4:00 PM EDT
52.73
+0.01 (0.02%)
After-hours: Apr 2, 2026, 7:01 PM EDT
Terns Pharmaceuticals Employees
Terns Pharmaceuticals had 59 employees as of December 31, 2024. The number of employees decreased by 7 or -10.61% compared to the previous year.
Employees
59
Change (1Y)
-7
Growth (1Y)
-10.61%
Revenue / Employee
n/a
Profits / Employee
-$1,630,627
Market Cap
6.08B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 59 | -7 | -10.61% |
| Dec 31, 2023 | 66 | 20 | 43.48% |
| Dec 31, 2022 | 46 | 5 | 12.20% |
| Dec 31, 2021 | 41 | 11 | 36.67% |
| Dec 31, 2020 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Rhythm Pharmaceuticals | 414 |
| Mirum Pharmaceuticals | 372 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Protagonist Therapeutics | 132 |
TERN News
- 2 days ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 10 days ago - Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst - Benzinga
- 10 days ago - Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC
- 10 days ago - Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma - Reuters
- 10 days ago - Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns - WSJ
- 10 days ago - Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) - GlobeNewsWire
- 10 days ago - Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports - Reuters
- 5 weeks ago - Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences - GlobeNewsWire